Securities, Shareholder Derivative, And Complex Litigation Attorney
CurrentWith 10 years’ practice experience, I focus my law practice on securities, shareholder derivative, and complex litigation on behalf of institutional and individual investors in federal and state courts nationwide. Representative matters include:• In re Twitter, Inc. Shareholder Derivative Litigation (Del. Ch.): Recouped $38 million and negotiated robust corporate governance reforms for the Company arising from certain Twitter directors’ and officers’ alleged breaches of fiduciary duties by issuing materially false and misleading statements about Twitter’s user growth and user engagement prospects, including by misrepresenting and concealing certain relevant user metrics. • Gerneth v. Chiasma et al. (D. Mass.): Secured $18.75 million settlement on behalf of a proposed class of investors alleging the biopharmaceutical company, Chiasma, Inc., misled investors in its 2015 initial public offering about the prospects for regulatory approval of the company’s drug candidate, Mycapssa, in violation of §§ 11 and 15 of the Securities Act of 1933.“2022 Georgia Rising Star” by Super Lawyers“AV Preeminent Peer Rating” by Martindale-Hubbell